Phibro Animal Health Co. to Issue Quarterly Dividend of $0.12 (NASDAQ:PAHC)

Phibro Animal Health Co. (NASDAQ:PAHC) declared a quarterly dividend on Tuesday, February 4th,RTT News reports. Investors of record on Wednesday, March 5th will be paid a dividend of 0.12 per share on Wednesday, March 26th. This represents a $0.48 dividend on an annualized basis and a yield of 2.15%. The ex-dividend date is Wednesday, March 5th.

Phibro Animal Health has a payout ratio of 25.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Phibro Animal Health to earn $1.92 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 25.0%.

Phibro Animal Health Stock Up 1.6 %

Shares of Phibro Animal Health stock opened at $22.37 on Thursday. Phibro Animal Health has a 52-week low of $10.03 and a 52-week high of $25.98. The company has a 50 day moving average of $21.89 and a 200 day moving average of $21.60. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The company has a market capitalization of $905.99 million, a P/E ratio of 52.02, a P/E/G ratio of 0.56 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. As a group, research analysts forecast that Phibro Animal Health will post 1.62 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Barclays raised their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a report on Wednesday, January 29th. Finally, Morgan Stanley lifted their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus target price of $20.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.